T.J.M. de Witte
- Hematology top 1%
- Molecular Biology
- Genetics top 5%
- Oncology top 10%
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Joop H. JansenBert A. van der ReijdenNicole BlijlevensJ. Peter DonnellyÉliane GluckmanVolker RundeReinier RaymakersPetra Muus
- Topics
- Acute Myeloid Leukemia Research (15 papers)Hematopoietic Stem Cell Transplantation (14 papers)Acute Lymphoblastic Leukemia research (4 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- NetherlandsFranceItaly
In The Last Decade
T.J.M. de Witte
28 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 72
- Hematology 766
- Molecular Biology 352
- Genetics 304
- Oncology 242
- Public Health, Environmental and Occupational Health 161
Countries citing papers authored by T.J.M. de Witte
This map shows the geographic impact of T.J.M. de Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.J.M. de Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.J.M. de Witte more than expected).
Fields of papers citing papers by T.J.M. de Witte
This network shows the impact of papers produced by T.J.M. de Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.J.M. de Witte. The network helps show where T.J.M. de Witte may publish in the future.
Co-authorship network of co-authors of T.J.M. de Witte
This figure shows the co-authorship network connecting the top 25 collaborators of T.J.M. de Witte. A scholar is included among the top collaborators of T.J.M. de Witte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.J.M. de Witte. T.J.M. de Witte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 22 | |
| 3 | 17 | |
| 4 | 83 | |
| 5 | 46 | |
| 6 | 22 | |
| 7 | Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. | 63 |
| 8 | 58 | |
| 9 | 15 | |
| 10 | Chimerism patterns in subpopulations of PBMCs in stable mixed chimeras after T-cell depleted SCT | 0 |
| 11 | 22 | |
| 12 | A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation. | 11 |
| 13 | 12 | |
| 14 | 82 | |
| 15 | Allogeneic and autologous stem cell transplantation in myelodysplastic syndromes. | 3 |
| 16 | Clonal predominance of cytomegalovirus-specific CD8+ cytotoxic T lymphocytes in bone marrow recipients. | 24 |
| 17 | Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. | 55 |
| 18 | Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). | 99 |
| 19 | 2 | |
| 20 | 20 |
About T.J.M. de Witte
T.J.M. de Witte is a scholar working on Hematology, Oncology and Molecular Medicine, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Hematology (766 citations), Genetics (304 citations) and Oncology (242 citations). T.J.M. de Witte has collaborated with scholars based in Netherlands, France and Italy. Frequent co-authors include Joop H. Jansen, Bert A. van der Reijden, Nicole Blijlevens, J. Peter Donnelly, Éliane Gluckman, Volker Runde, Reinier Raymakers, Petra Muus, Marc H.G.P. Raaijmakers and Aloïs Gratwohl. Their work appears in journals such as Blood, Clinical Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.